Metformin administration during pregnancy attenuated the long-term maternal metabolic and cognitive impairments in a mouse model of gestational diabetes.

Aging
Yalan ZhaoPhilip N Baker

Abstract

Gestational diabetes mellitus (GDM) is a metabolic disease that can have long-term adverse effects on the cognitive function of mothers. In our study, we explored the changes in metabolic health and cognitive function in mice of middle- and old- age after exposure to GDM, and whether metformin therapy during pregnancy provided long-term benefits. Mice with GDM demonstrated significant cognitive impairment in old age, which was associated with insulin resistance. Gestational metformin therapy was shown to increase insulin sensitivity and improve cognition. The ovarian aging rate was also accelerated in mice exposed to GDM during pregnancy, which may be related to fatty acid metabolism in the ovaries. Treatment with metformin during pregnancy was shown to improve fatty acid metabolism in ovarian tissues. During pregnancy, mice were fed with a high-fat diet (GDM group) or a low-fat diet (Control group), and a third group received metformin while receiving a high-fat diet (Treatment group). At 12 months old, the mice completed an oral glucose tolerance test, insulin tolerance test, Morris water maze test, female sex hormones were measured, and metabolite profiles of tissue from the ovaries, hypothalamus, and pituitary glands were a...Continue Reading

References

Oct 1, 1992·Psychoneuroendocrinology·S M Phillips, B B Sherwin
Mar 15, 2005·The Journal of Clinical Investigation·Thomas A Buchanan, Anny H Xiang
Oct 20, 2005·Journal of Bioscience and Bioengineering·C LiuS Hwang
Feb 17, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Julie DumasPaul Newhouse
Apr 26, 2008·Endocrine Reviews·Christopher T Kodl, Elizabeth R Seaquist
Jul 30, 2008·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Denice S FeigJanet E Hux
Sep 30, 2008·Arquivos brasileiros de endocrinologia e metabologia·Eliana M Da Ros WendlandMaria Inês Schmidt
Jul 11, 2009·Endocrine Reviews·F J BroekmansB C Fauser
Mar 9, 2010·Revista española de geriatría y gerontología·Raúl López-GruesoJosé Viña
Mar 17, 2010·Life Sciences·Akiko SakataMasatsugu Horiuchi
Aug 28, 2010·Diabetes·Jie DingUNKNOWN Edinburgh Type 2 Diabetes Study Investigators
Nov 29, 2011·Clinical Science·Benoit ViolletFabrizio Andreelli
Dec 14, 2011·Dementia and Geriatric Cognitive Disorders Extra·Hiroyuki UmegakiTakahisa Sano
Jan 4, 2012·Annals of the New York Academy of Sciences·Emily Jane Gallagher, Derek LeRoith
Mar 27, 2012·Diabetes Research and Clinical Practice·Lina PeiYingyan Zhang
Jun 23, 2012·Pharmacogenetics and Genomics·Li GongTeri E Klein
Sep 28, 2013·European Journal of Pharmacology·Brenna CholertonSuzanne Craft
Jun 6, 2015·Annals of Nutrition & Metabolism·Kamana KcHua Zhang
Jun 11, 2015·Human Reproduction Update·Negar NaderpoorHelena J Teede
Jun 26, 2015·Physiological Reviews·Yuko HaraJohn H Morrison
Aug 24, 2016·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Ye Feng, Huixia Yang
May 13, 2017·BioMed Research International·Claudia Caissutti, Vincenzo Berghella

❮ Previous
Next ❯

Methods Mentioned

BETA
genetic modifications
PCA
gene knockout
ELISA

Software Mentioned

DA
MassOmics )
AMDIS ChemStation
Metaboanalyst
house R
R package “ pwr2 ”
OPLS

Related Concepts

Related Feeds

Aging Genetics (Keystone)

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.